|
HS Code |
537735 |
| Chemical Name | Calcium hydroxyapatite |
| Chemical Formula | Ca10(PO4)6(OH)2 |
| Molar Mass | 1004.6 g/mol |
| Appearance | White crystalline powder |
| Solubility In Water | Insoluble |
| Cas Number | 1306-06-5 |
| Density | 3.16 g/cm3 |
| Ph | Basic, around 9-10 in suspension |
| Biocompatibility | High |
| Uses | Bone grafting, dental implants, coatings for medical implants |
| Structure Type | Hexagonal |
| Hardness | 5 on Mohs scale |
As an accredited Durapatite factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Durapatite is packaged in a sealed, amber glass bottle containing 100 grams, labeled with chemical details, safety symbols, and handling instructions. |
| Shipping | Durapatite should be shipped in tightly sealed containers, clearly labeled, and protected from moisture and contamination. The packaging must comply with local and international regulations for chemicals. During transport, avoid extreme temperatures, physical damage, and incompatible substances to maintain its integrity and safety. Handle with appropriate protective equipment. |
| Storage | Durapatite should be stored in a tightly closed container, in a cool, dry, and well-ventilated area. Protect it from moisture, direct sunlight, and incompatible substances such as strong acids. Keep it away from food and incompatible materials. Always follow laboratory safety protocols, including the use of personal protective equipment, and ensure proper labeling and secure storage to prevent contamination or accidental exposure. |
Applications of Durapatite in Industrial ManufacturingDurapatite, as a high-purity, synthetic form of calcium phosphate, serves as a fundamental ingredient in several advanced manufacturing settings. Our facility supplies consistent material meeting stringent downstream performance metrics, supporting industries that demand precise control over mineral content and a guaranteed compliance pedigree through all stages of product realization. 1. Dental Biomaterials ManufacturingDurapatite is integral to dental restorative product manufacturing, where it functions as a primary phase mineral for enamel and dentin substitutes in restorative and preventative devices. Production plants depend on its biocompatibility profile, matching natural hydroxyapatite, to formulate high-strength dental cements, prosthetic coatings, and direct filling media that require certified mineral content and controlled particle size distribution for successful end-use application. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Orthopedic Implant CeramicsThe orthopedic segment employs our material as the primary mineral in synthetic bone grafts, granules, and porous matrices, relying on high bioactivity and osseointegration characteristics. Manufacturing sites utilize Durapatite in the production of non-load and moderate-load bearing implant devices, prioritizing microstructural purity, resorption profile, and compliance for regulated healthcare markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Nutritional and Food Additive BlendingIn the food and nutraceutical industry, manufacturers employ Durapatite as a fortified mineral additive for calcium-enriched beverages, powders, and supplements, leveraging its regulated dietary ingredient status and controlled particle distribution to deliver bioavailable calcium and phosphorus. Food plants manage blending protocols to prevent agglomeration and maintain homogeneous dispersion in fortified products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Biomedical Coating for Surgical DevicesAdvanced device manufacturers utilize our material as the mineral source for bioactive plasma spray and sol-gel coatings on titanium and stainless steel implant surfaces. This process produces an integrative interface between implant metals and host tissue, controlling thickness, crystallinity, and surface coverage to meet the latest regulatory directives for medical device safety and performance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Ceramics for Analytical and LaboratorywareCeramic manufacturers select this material for the production of high-purity laboratory crucibles, evaporation boats, and analytical ware, taking advantage of its resistance to high temperatures and chemical degradation. Production control relies on tight particle sizing, low impurity profile, and process stability during sintering and finishing to achieve inert end products suitable for sensitive assay and synthesis environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
6. Animal Feed Phosphorus FortifiersDurapatite finds application in animal nutrition as a source of bioavailable phosphorus and calcium, enhancing mineral balance in formulated feed for poultry, swine, and aquaculture. Feed manufacturers favor its low contaminant profile and positive regulatory status, allowing precise feeding program design to promote animal growth, health, and skeletal strength under intensive production conditions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Durapatite prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Long nights at the reactor have taught us that the smallest variables—drying rates, atmosphere quality, the exact grade of reagent—shape the final result more than any marketing brochure ever admits. We started producing Durapatite two decades ago, convinced that those working at the edge of material science and medicine need consistent calcium phosphate if they’re going to trust it in their process. The name Durapatite signals more than hydroxyapatite powder; it stands for the discipline behind controlling stoichiometry, the discipline behind controlling particle size, and the patience to scale these up in batches that match every time.
For most chemical manufacturers, it’s tempting to talk up “high purity” like it’s a checkmark. Our engineers have spent years fussing over calcium carbonate sources, chasing trace iron out, rejecting entire shipments for organics that others would overlook. If Durapatite is to support surgeons, implant developers, or ceramic researchers, every impurity is an unwanted experiment. We regularly measure for heavy metals, rare earths, silicon, and non-stoichiometric calcium. Our standard model, Durapatite HA-99, consistently measures above 99.5% purity on a dry solid basis. We take samples at every stage, confirm phase by X-ray diffraction, and audit ourselves with academic partners. We don’t send it out the door if it can’t back up the number on the label with independent results.
Colloidal suspensions, pastes, sinterable powders—these are industry terms, but at the bench, the question is: is it fine enough, or coarse enough, to do what you need without constant troubleshooting? Particle size isn’t just about numbers on a laser diffraction readout. Our micronized grade averages under two microns, ideal for bone cements or densifying ceramics without leaving voids. Fine powder lets resorbable scaffolds copy the nanostructures found in nature. At the other end, we offer a coarser version for filtration, or for forming granules that survive through tablet formation. Size uniformity stems from investments in spray drying and air classifying, not from a one-size-fits-all line. This means if you need Durapatite for a rotary press or for injection into a bioceramic, you won’t be forced to grind it yourself or rework formulations batch to batch.
We don’t just make a calcium phosphate with a calcium-to-phosphorus ratio near 1.67 because it fits a textbook. This ratio drives not only biocompatibility but also how well the hydroxyapatite integrates in biological and industrial environments. Deviations lead to unwanted resorption rates in implants, unpredictable solubility, or shifting XRF results. In our reactors, we monitor not just bulk C/P ratio but also phosphate speciation—making sure each crystal lattice is what we say it is. We’ve seen labs run trial batches from other sources where acid reactivity or dissolution wasn’t what patent literature predicted. With Durapatite, researchers across dental, medical, and specialty ceramic fields know every order will behave like the last.
There’s a difference between hydroxyapatite that meets pharmaceutical or medical standards and one meant for livestock or low-end ceramics. Lower grade materials often contain more heavy metals, less phase purity, and wider particle size ranges. They might suit an agricultural customer or a water treatment plant. But in the lab, when a paste forms poorly or a composite delaminates, guesswork at the material quality level isn’t an option. We’ve lost bids to suppliers promising “just as good” products—then spent years winning back trust after their products under-delivered. Our emphasis on reproducibility and traceability grows from the technical demands of our best clients, not from an attempt to upcharge. You feel the difference in failed pilot lines that stop failing, in animal studies that don’t surprise, and in regulatory filings that pass without extra questions.
Orthopedic companies depend on hydroxyapatite for bone augmentation, dental manufacturers use it in enamel repair, and regenerative medicine startups coat their scaffolds with it for stem cell research. These applications demand consistent behavior. Customers bring us concerns: Does the powder sinter at the same temperature every time? Does it interact with collagen or other excipients as expected? Did the last shipment really match the previous year for porosity and surface area? For years, we partnered with implant makers on multi-year studies, checking not only the reactivity profile of Durapatite but the fate of every impurity. These collaborations push us to upgrade our processes, not settle for whatever the broker on the phone wants to sell.
Scaling up any mineral process brings risk. Sometimes the hydrothermal crystal growth goes awry; sometimes a filtration error lets through fines or unreacted precursors. Early on, we built redundancy into every reactor line, running parallel sampling for each tank. Now that several of the world’s most demanding universities and multinationals depend on us, we can’t afford to skip a single analysis cycle. Our line operators log pH, monitor redox, and check XRD signatures in-house. Instead of leaving drying to chance, we automated granulation and post-treatment so the particle morphologies match every time. Consistent product isn’t a cost—it’s the only way we stay in business.
Techniques that were “good enough” in the 2000s don’t cut it now, especially for applications headed for medical device regulation. We started using advanced seeding and controlled nucleation runs, which helped lower trace carbonate substitution and phosphate vacancies. This matters to researchers coating prosthetic stems or working on slow-release drug depots; less crystal imperfection means slower, more predictable reabsorption. Pure hydroxyapatite with fewer defects also leads to less inflammation response in vivo—a lesson that didn’t come from theory but from real animal studies, whose results we follow closely when customers share their data with us. We work to hit less than 2% lattice substitution on all medical-grade output.
Surface reactivity dictates how powders behave in composites or biological environments. We tweak our precipitation process to achieve a midrange surface area suitable for most resin or polymer blends—not so high that it clumps or causes unpredictable fast resorption, not so low that it behaves like an inert filler. We’ve had customers bring us results from competing materials, asking why their resorbable bone cements either set too slowly or break down too fast. Often, it comes down to poorly controlled surface area or overlooked amorphous phases. By running both BET and chemisorption analysis on every batch, we make sure Durapatite behaves predictably—eliminating many of the “trial and error” headaches typical in scale-up.
Even with our controls, some orders don’t go out. Scaling laboratory conditions to the pilot and then to regular production brings out new challenges every year. We keep a separate quality control lab, re-testing for trace elements and running thermal stability simulation before release. If a batch doesn’t meet our phase or particle targets, we pull it—no exceptions. Once, after upgrading to a new mixer, trace micronutrient contamination spiked in a single lot; our commitment to full recall procedures made for an expensive two weeks, but several critical customers thanked us for catching it before their internal testing did. Mistakes happen at every plant, but learning from them keeps failures rare and customer confidence high.
Every region we serve—North America, Europe, Asia—brings its own regulatory hurdles. The CE labeling for medical materials grows stricter every year; US FDA submissions require raw material traceability and biological evaluations, not just a printed COA. We invest heavily in documentation and track-and-trace abilities across our production lots, supplying full validation reports on request. Some clients walk us through their audit checklists, demanding certificates not only for the final powder, but for each input. We meet them step for step, because our own teams also rely on our traceability. By building robust data packs, we help clients shorten approval timelines and avoid regulatory setbacks due to questionable raw material choices.
University teams push us hardest—they run three parallel syntheses, seed with a new protein, or mill the powder with chemical dopants that change crystal structure. Our experience grows from years of customer feedback. Some universities test Durapatite in stem cell experiments, monitoring cell adhesion versus that of nano-flash sintered grades. Others work on dentin remineralization and need extreme nanoparticle dispersion. We stay connected to their feedback, working to tune not just the mean particle size but its range and shape—sometimes shifting our spray drying curves or adding a secondary sieving step. By listening, we help them avoid surprises and get quicker publication results.
Commodity hydroxyapatite can often be sourced from a variety of chemicals and processes, leading to inconsistencies. Our supply chain locks in high-purity calcium and phosphorus without agricultural byproducts or recycled minerals. Competitors sometimes compromise on source material quality, introducing trace contaminants. Their powders often lack the phase uniformity essential for critical medical uses, or suffer from broader size variability that complicates formulations. Over the years, we’ve outperformed standard grades in both third-party dissolution and resorption testing. Our careful phase verification and consistent particle sizing underpins why research hospitals and OEMs specify Durapatite by model, not just as “any hydroxyapatite.”
Engineering reliable chemical products means taking environmental responsibility seriously. Our wastewater treatment lines run on closed loop, capturing and recycling nearly 90% of water used in precipitation. We operate our reactors on renewable energy and track emissions opposite the latest state and national standards. Responsible sourcing for calcium and phosphate inputs keeps our carbon footprint lower than the chart average for mineral syntheses. We see increasing requests from universities and international manufacturers for full environmental impact documentation; we make this available for every order.
Not every customer arrives with a polished protocol or established product line. Early-stage biotech companies and academic labs come to us with new ideas—3D printed scaffolds, composite dental blocks, or slow-dissolve coatings. We thrive on technical questions: Can we adapt a process for higher porosity? Can we add a spec for agglomerate resistance? Rather than hand over stock material and hope for the best, we invite these clients to pilot tests, modify batch composition if needed, or offer custom-milled runs for research. Many successful medical and dental launches start in these collaborations.
Timely shipment matters—so does knowing exactly where each drum came from. Some suppliers fall short when a shipment arrives late, out of spec, or without paperwork matching regulatory needs. Our team manages a digital inventory system that matches every batch delivered with a paper and digital trail, giving clients rapid access to every data point from synthesis to arrival on site. Auditors and clients regularly check our traceability practices, and we make our logs available for their own regulatory submissions or patent filings.
The chemical side of hydroxyapatite will always present challenges as technology evolves. Customer feedback shapes our processes, raw material selection, and even packaging. For example, biomedical implant companies asked us to seal every drum with a tamper-evident, nitrogen flush, keeping powders dry and phase-pure through months of shipping and storage. Others wanted custom certifications for select heavy metals, and we invested in higher-sensitivity ICP-MS instrumentation to meet their requirements. Strong relationships stem from solving these problems collaboratively, delivering more than just powder—delivering confidence.
Materials demands continue to rise, and the science behind bone regeneration, dental care, and bioceramics never rests. Our current R&D projects focus on ultra-fine nanoparticle synthesis, bringing surface chemistry to an even tighter specification, and supporting next-generation additive manufacturing techniques. Early test runs already show promise for micro-molding and high-aspect ratio printing. We’re expanding cleanroom protocols to further reduce risk of micronutrient contamination and plan process changes to cut residual chloride or sulfate to below-perceptible levels for the pharma market. Every lesson from a customer complaint, failed lot, or breakthrough gets built straight back into our process.
Durapatite wasn’t born from a whiteboard or a focus group. Its strengths come from listening to researchers who had trouble with cheap, unpredictable materials; from medical device engineers frustrated by failed production runs; from years in the factory watching which variables really matter. We measure our success in better results and fewer surprises for our partners. Anyone working on the edge of science or medicine deserves a mineral product that acts as steady as their data. Durapatite offers that steadiness, batch after batch, because that’s what we’d demand if we stood in your shoes.